跳至主要内容
临床试验/NCT00446186
NCT00446186已完成2 期

Mk0476 Phase II Dose Finding Study -Allergic Rhinitis-

Organon and Co0 个研究点目标入组 945 人开始时间: 2004年2月最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
945
主要终点
The change from baseline in the composite nasal symptoms score (average over the 2-week treatment period) in seasonal allergic rhinitis

研究概览

简要总结

The clinical study evaluates the efficacy and safety of MK0476 in adult patients with allergic rhinitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with seasonal allergic rhinitis

排除标准

  • Patients who have nasal diseases (e.g., nasal polyp, septonasal arcuation, hypertrophic rhinitis), upper respiratory infection, sinusitis, infectious rhinitis, ocular infection and those disease severe enough to interfere with assessment of effectiveness
  • Patients who have rhinitis medicamentosa, or nonallergic rhinitis (e.g., vasomotor rhinitis, eosinophilia rhinitis)
  • Patient has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease

结局指标

主要结局

The change from baseline in the composite nasal symptoms score (average over the 2-week treatment period) in seasonal allergic rhinitis

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验